Flow-through cross-polarized imaging as a new tool to overcome the analytical sensitivity challenges of a low-dose crystalline compound in a lipid matrix

dc.accessRightsAnonymous
dc.audienceScience
dc.contributor.authorAdler, Camille
dc.contributor.authorSchönenberger, Monica
dc.contributor.authorTeleki, Alexandra
dc.contributor.authorLeuenberger, Bruno
dc.contributor.authorKuentz, Martin
dc.date.accessioned2015-12-22T20:08:49Z
dc.date.available2015-12-22T20:08:49Z
dc.date.issued2015-11-10
dc.description.abstractAssessing the physical state of a low-dose active compound in a solid lipid or polymer matrix is analytically challenging, especially if the matrix exhibits some crystallinity. The aim of this study was first to compare the ability of current methods to detect the presence of a crystalline model compound in lipid matrices. Subsequently, a new technique was introduced and evaluated because of sensitivity issues that were encountered with current methods. The new technique is a flow-through version of cross-polarized imaging in transmission mode. The tested lipid-based solid dispersions (SDs) consisted of β-carotene (BC) as a model compound, and of Gelucire 50/13 or Geleol mono- and diglycerides as lipid matrices. The solid dispersions were analyzed by (hyper) differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD), and microscopic techniques including atomic force microscopy (AFM). DSC and XRPD could analyze crystalline BC at concentrations as low as 3% (w/w) in the formulations. However, with microscopic techniques crystalline particles were detected at significantly lower concentrations of even 0.5% (w/w) BC. A flow-through cross-polarized imaging technique was introduced that combines the advantage of analyzing a larger sample size with high sensitivity of microscopy. Crystals were detected easily in samples containing even less than 0.2% (w/w) BC. Moreover, the new tool enabled approximation of the kinetic BC solubility in the crystalline lipid matrices. As a conclusion, the flow-through cross-polarized imaging technique has the potential to become an indispensable tool for characterizing low-dose crystalline compounds in a lipid or polymer matrix of solid dispersions.
dc.identifier.doi10.1016/j.jpba.2015.06.033
dc.identifier.issn0731-7085
dc.identifier.issn1873-264X
dc.identifier.urihttp://hdl.handle.net/11654/11957
dc.language.isoen
dc.publisherElsevieren_US
dc.relation.ispartofJournal of Pharmaceutical and Biomedical Analysisen_US
dc.subjectAnalytical toolsen_US
dc.subjectCrystalline active compounden_US
dc.subjectFlow-through cross-polarized imagingen_US
dc.subjectSampling issuesen_US
dc.subjectSensitivity limitsen_US
dc.subjectSolid lipid formulationsen_US
dc.titleFlow-through cross-polarized imaging as a new tool to overcome the analytical sensitivity challenges of a low-dose crystalline compound in a lipid matrix
dc.type01A - Beitrag in wissenschaftlicher Zeitschrift
dc.volume115
dspace.entity.typePublication
fhnw.InventedHereYes
fhnw.IsStudentsWorkno
fhnw.PublishedSwitzerlandNo
fhnw.ReviewTypeAnonymous ex ante peer review of a complete publication
fhnw.affiliation.hochschuleHochschule für Life Sciences FHNWde_CH
fhnw.affiliation.institutInstitut für Pharma Technologyde_CH
fhnw.pagination20-30
fhnw.publicationStatePublished
relation.isAuthorOfPublication68819448-8611-488b-87bc-1b1cf9a6a1b4
relation.isAuthorOfPublication.latestForDiscovery68819448-8611-488b-87bc-1b1cf9a6a1b4
Dateien

Lizenzbündel

Gerade angezeigt 1 - 1 von 1
Kein Vorschaubild vorhanden
Name:
license.txt
Größe:
2.94 KB
Format:
Item-specific license agreed upon to submission
Beschreibung: